Duality Biotherapeutics, Inc. (09606.HK)株価、チャート、ニュース、およびAI分析

Q: DUALITYBIO-B の株価パフォーマンスは？

DUALITYBIO-B の現在の価格は $359 で、最終取引日から 1.04% 減少 変動しました。

Q: Duality Biotherapeutics, Inc. の主な事業テーマや業界は？

Duality Biotherapeutics, Inc. は Biotechnology 業界、セクターは Health Care に属しています。

Q: Duality Biotherapeutics, Inc. の時価総額はいくらですか？

Duality Biotherapeutics, Inc. の現在の時価総額は $31.6B です。

ホーム

株式

09606.HK

DUALITYBIO-B (09606.HK)

Duality Biotherapeutics, Inc.

HK$359

-1.04%

$-3.8

休場: Jan 16, 16:00:00 HKT

主要データ

前終値

$362.8

始値

$362.8

当日レンジ

$351.8 - $364.8

52週レンジ

$165.5 - $563.5

取引高

689.5K

平均取引高

1.2M

1株当たり利益(TTM)

-35.81

配当利回り

時価総額

$31.6B

DUALITYBIO-Bとは何ですか？

Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.

特徴

取引戦略